Results
1 -
10 of
20Reaper et al..
Selective killing of ATM or p53 deficient cancer cells through inhibition of ATR, Nature Chemical Biology, 2011 Fedorov O., Marsden B., Pogacic V., Rellos P., Muller S., Bullock A. N., Schwaller J., Sundstrom M., Knapp S..
A systematic interaction map of validated kinase inhibitors with Ser/Thr kinases, Proceedings of the National Academy of Sciences, 2007 Irinotecan and DNA-PKcs inhibitors synergize in killing of colon cancer cells, Investigational New Drugs DNA-PK in CLL Chemotherapy, Advances in DNA Repair in Cancer Therapy A Human Cell Extract-Based Assay for the Activation of ATM and ATR Checkpoint Kinases, Cell Cycle Checkpoints Targeting DNA-PK as a Therapeutic Approach in Oncology, Targeting the DNA Damage Response for Anti-Cancer Therapy Inhibition of DNA-dependent protein kinase reduced palmitate and oleate-induced lipid accumulation in HepG2 cells, European Journal of Nutrition Radio-sensitization of human leukaemic MOLT-4 cells by DNA-dependent protein kinase inhibitor, NU7441, Radiation and Environmental Biophysics Inhibition of DNA-dependent protein kinase catalytic subunit by small molecule inhibitor NU7026 sensitizes human leukemic K562 cells to benzene metabolite-induced apoptosis, Journal of Huazhong University of Science and Technology [Medical Sciences] Targeting DNA-PKcs increased anticancer drug sensitivity by suppressing DNA damage repair in osteosarcoma cell line MG63, Tumor Biology